To assess the serological biomarkers in BCLC Stage B & C hepatocellular cancer patients undergoing treatment
Latest Information Update: 20 May 2022
At a glance
- Drugs Doxorubicin (Primary) ; Sorafenib (Primary) ; Yttrium-90 (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
Most Recent Events
- 20 May 2022 New trial record
- 13 Apr 2022 Results presented at the 113th Annual Meeting of the American Association for Cancer Research